Mei Fong Pang
About Mei Fong Pang
Mei Fong Pang is a Senior Scientist with extensive expertise in immuno-oncology, cancer biology, and chronic inflammation disease. She has held various research positions at notable institutions, including Princeton University and Insmed Incorporated, and has a strong academic background in Genetics, Molecular Biology, and Medical Science.
Current Role at Insmed
Mei Fong Pang serves as a Senior Scientist at Insmed Incorporated, a position she has held since 2022. In this role, she applies her extensive scientific expertise to contribute to the company's research and development efforts. Her work focuses on advancing therapeutic solutions, particularly in areas related to immuno-oncology and chronic inflammation diseases.
Previous Experience at Visikol Inc
Prior to her current role, Mei Fong Pang worked as a Scientist at Visikol Inc from 2020 to 2021. During her nine-month tenure, she engaged in research activities that supported the company's objectives in the field of scientific imaging and analysis.
Education and Expertise in Genetics and Molecular Biology
Mei Fong Pang earned her Bachelor’s Degree in Genetics and Molecular Biology from Universiti Malaya, studying from 2002 to 2005. She furthered her education at the same institution, obtaining a Master’s Degree in Science (Metagenomics) from 2006 to 2008. Her academic background laid the foundation for her expertise in multiple scientific disciplines, including gene therapy using adeno-associated virus (AAV).
Research and Academic Background
Mei Fong Pang has a robust academic and research background. She completed her Ph.D. in Medical Science at Karolinska Institute from 2009 to 2013. Following her doctoral studies, she served as a Postdoctoral Research Fellow at Princeton University from 2013 to 2018. Her experience also includes roles as a Research Specialist and Senior Scientist at Princeton University and CHUGAI PHARMABODY RESEARCH PTE. LTD., respectively.
Publications and Scientific Contributions
Mei Fong Pang has a proven track record of publishing research in high-impact scientific journals. Her contributions to the field are recognized through her extensive experience in designing, executing, and interpreting complex scientific experiments, particularly in cancer biology and immuno-oncology.